The influence of inflammation on cardiovascular disease in women.
Date
2022-10-11Journal
Frontiers in global women's healthType
Article
Metadata
Show full item recordAbstract
The onset of cardiovascular disease in women is almost a decade later than men, partly due to the protective effect of estrogen prior to menopause. Recently, it was noted that while there have been advances in improving the morbidity and mortality from CVD in women older than 55 years, the improvement in younger women has been stagnant. The mechanism behind this lag is unclear. This manuscript reviews the literature available on the sex-specific inflammatory response in the context of traditional and non-traditional cardiovascular disease risk factors. Our review suggests that women have a differential inflammatory response to various disease states that increases their risk for CVD and warrants a distinct prioritization from men when calculating cardiovascular disease risk.Rights/Terms
© 2022 Kottilil and Mathur.Identifier to cite or link to this item
http://hdl.handle.net/10713/20104ae974a485f413a2113503eed53cd6c53
10.3389/fgwh.2022.979708
Scopus Count
Collections
Related articles
- Cardiovascular Disease in Women Update: Ischemia, Diagnostic Testing, and Menopause Hormone Therapy.
- Authors: Prabakaran S, Vitter S, Lundberg G
- Issue date: 2022 Feb
- Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
- Authors: LaRosa JC
- Issue date: 1992 Summer
- Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis.
- Authors: Muka T, Oliver-Williams C, Kunutsor S, Laven JS, Fauser BC, Chowdhury R, Kavousi M, Franco OH
- Issue date: 2016 Oct 1
- Cardiovascular disease in women and noncontraceptive use of hormones: a feminist analysis.
- Authors: MacPherson KI
- Issue date: 1992 Jun